The effect of component of cream for topical delivery of hesperetin

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 5, 2010, Pages 611-614

  Huang, Yaw Bin ^a   Lee, Ko Feng ^a   Huang, Chi Te ^a   Tsai, Yi Hung ^a   Wu, Pao Chu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cream; Hesperetin; Skin irritation; Whitening effect

Indexed keywords

ALCOHOL; GLYCEROL; HESPERETIN; LAUROCAPRAM; LINOLEIC ACID; MACROGOL 400; MENTHOL; PHOSPHATIDYLCHOLINE; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREAM; DEPIGMENTATION; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MALE; NONHUMAN; RAT; SKIN COLOR; SKIN IRRITATION; SKIN PERMEABILITY;

ADMINISTRATION, TOPICAL; ANIMALS; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; GUINEA PIGS; HESPERIDIN; MALE; PIGMENTATION; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SOLUBILITY;

EID: 77951722875     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.611     Document Type: Article

References (26)

1. Maeda K., Naganuma M., J. Photochem. Photobiol. B, 47, 136-141 (1998).
2. Bian S., Doh H. J., Zheng J., Kim J. S., Lee C. H., Kim D. D., Eur. J. Pharm. Sci., 18, 141-147 (2003).
3. Bonina F., Lanza M., Montenegro L., Puglisi C., Tomaino A., Trombetta D., Castelli F., Saija A., Int. J. Pharm., 145, 87-94 (1996).
4. Schoemaker J. H., Bousema M. T., Zijlstra H., van der Horst F. A., Dermatology, 191, 36-38 (1995).
5. Mortimer P. S., Angiology, 48, 87-91 (1997).
6. Saija A., Tomaino A., Lo Cascio R., Rapisarda P., Dederen J. C., Int. J. Cosmet. Sci., 20, 331-342 (1998).
7. Williams A. C., Barry B. W., Pharm. Res., 8, 17-24 (1991).
8. Kabayashi D., Matsuzawa T., Sugibayashi K., Morimoto Y., Kimura M., Pharm. Res., 11, 96-102 (1994).
9. Wu H., Ramachandran C., Weiner N. D., Roessler B. J., Int. J. Pharm., 220, 63-75 (2001).
10. Garg A., Garg S., Zaneveld L. J. D., Singla A. K., Phytother. Res., 15, 655-669 (2001).
11. Kanaze F. I., Kokkalou E., Georgarakis M., Niopas I., J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 801, 363-367 (2004).
12. Fang J. Y., Tsai M. J., Huang Y. B., Wu P. C., Tsai Y. H., Drug Dev. Res., 40, 56-67 (1997).
13. Huang Y. B., Chang J. S., Liu J. C., Tsai M. J., Tsai Y. H., Wu P. C., Drug Dev. Ind. Pharm., 30, 163-169 (2004).
14. Havsteen B., Biochem. Pharmacol., 32, 1141-1148 (1983).
15. Ando H., Funasaka Y., Oka M., Ohashi A., Furumura M., Matsunaga J., Matsunaga N., Hearing V. J., Ichihashi M., J. Lipid Res., 40, 1312-1316 (1999).
16. Funasaka Y., Komoto M., Ichihashi M., Pigment Cell Res., 13 (Suppl. 8), 170-174 (2000).
17. Briganti S., Camera E., Picardo M., Pigment Cell Res., 16, 101-110 (2003).
18. Shigeta Y., Imanaka H., Ando H., Ryu A., Oku N., Baba N., Makino T., Biol. Pharm. Bull., 27, 591-594 (2004).
19. Mahjour M., Mauser B., Rashidbaigi A., Fawzi M. B., J. Controlled Release, 14, 243-252 (1990).
20. Shin S. C., Shin E. Y., Cho C. W., Drug Dev. Ind. Pharm., 26, 563-566 (2000).
21. Paolino D., Ventura C. A., Nistico S., Puglisi G., Fresta M., Int. J. Pharm., 244, 21-31 (2002).
22. Agyralides G. G., Dallas P. P., Rekkas D. M., Int. J. Pharm., 281, 35-43 (2004).
23. Chang J. S., Huang Y. B., Hou S. S., Wang R. J., Wu P. C., Tsai Y. H., Int. J. Pharm., 338, 48-54 (2007).
24. Wu P. C., Chang J. S., Huang Y. B., Chai C. Y., Tsai Y. H., Int. J. Pharm., 222, 225-235 (2001).
25. Lambert W. J., Higuchi W. I., Knutson K., Krill S. L., Pharm. Res., 6, 798-803 (1989).
26. Nagao A., Seki M., Kobayashi H., Biosci. Biotechnol. Biochem., 63, 1787-1790 (1999).